161 related articles for article (PubMed ID: 34550275)
1. A novel lncRNA-mRNA-miRNA signature predicts recurrence and disease-free survival in cervical cancer.
Li M; Tian X; Guo H; Xu X; Liu Y; Hao X; Fei H
Braz J Med Biol Res; 2021; 54(11):e11592. PubMed ID: 34550275
[TBL] [Abstract][Full Text] [Related]
2. Identification of a Multi-RNA-Type-Based Signature for Recurrence-Free Survival Prediction in Patients with Uterine Corpus Endometrial Carcinoma.
Wang P; Zeng Z; Shen X; Tian X; Ye Q
DNA Cell Biol; 2020 Apr; 39(4):615-630. PubMed ID: 32105510
[TBL] [Abstract][Full Text] [Related]
3. Identification and Function Analysis of a Five-Long Noncoding RNA Prognostic Signature for Endometrial Cancer Patients.
Tang H; Wu Z; Zhang Y; Xia T; Liu D; Cai J; Ye Q
DNA Cell Biol; 2019 Dec; 38(12):1480-1498. PubMed ID: 31539276
[TBL] [Abstract][Full Text] [Related]
4. A ceRNA network of BBOX1-AS1-hsa-miR-125b-5p/hsa-miR-125a-5p-CDKN2A shows prognostic value in cervical cancer.
Wang T; Zhang XD; Hua KQ
Taiwan J Obstet Gynecol; 2021 Mar; 60(2):253-261. PubMed ID: 33678324
[TBL] [Abstract][Full Text] [Related]
5. Identification of competitive endogenous RNAs network in breast cancer.
Wang X; Wan J; Xu Z; Jiang S; Ji L; Liu Y; Zhai S; Cui R
Cancer Med; 2019 May; 8(5):2392-2403. PubMed ID: 30932362
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Analysis of lncRNA-Mediated ceRNA Crosstalk and Identification of Prognostic Biomarkers in Wilms' Tumor.
Zheng H; Li BH; Liu C; Jia L; Liu FT
Biomed Res Int; 2020; 2020():4951692. PubMed ID: 32149111
[TBL] [Abstract][Full Text] [Related]
7. Recurrence-Associated Multi-RNA Signature to Predict Disease-Free Survival for Ovarian Cancer Patients.
Zhang Y; Ye Q; He J; Chen P; Wan J; Li J; Yang Y; Li X
Biomed Res Int; 2020; 2020():1618527. PubMed ID: 32149080
[TBL] [Abstract][Full Text] [Related]
8. Reconstruction of the lncRNA-miRNA-mRNA network based on competitive endogenous RNA reveal functional lncRNAs in Cerebral Infarction.
Zou JB; Chai HB; Zhang XF; Guo DY; Tai J; Wang Y; Liang YL; Wang F; Cheng JX; Wang J; Shi YJ
Sci Rep; 2019 Aug; 9(1):12176. PubMed ID: 31434962
[TBL] [Abstract][Full Text] [Related]
9. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
10. Identifying Molecular Markers of Cervical Cancer Based on Competing Endogenous RNA Network Analysis.
Qin S; Gao Y; Yang Y; Zhang L; Zhang T; Yu J; Shi C
Gynecol Obstet Invest; 2019; 84(4):350-359. PubMed ID: 30625468
[TBL] [Abstract][Full Text] [Related]
11. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
[TBL] [Abstract][Full Text] [Related]
12. A competing endogenous RNA network identifies novel mRNA, miRNA and lncRNA markers for the prognosis of diabetic pancreatic cancer.
Yao K; Wang Q; Jia J; Zhao H
Tumour Biol; 2017 Jun; 39(6):1010428317707882. PubMed ID: 28639886
[TBL] [Abstract][Full Text] [Related]
13. Signature microRNAs and long noncoding RNAs in laryngeal cancer recurrence identified using a competing endogenous RNA network.
Tang Z; Wei G; Zhang L; Xu Z
Mol Med Rep; 2019 Jun; 19(6):4806-4818. PubMed ID: 31059106
[TBL] [Abstract][Full Text] [Related]
14. The global expression profiling in esophageal squamous cell carcinoma.
Dai F; Mei L; Meng S; Ma Z; Guo W; Zhou J; Zhang J
Genomics; 2017 Jul; 109(3-4):241-250. PubMed ID: 28442363
[TBL] [Abstract][Full Text] [Related]
15. An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network.
Sun M; Wu D; Zhou K; Li H; Gong X; Wei Q; Du M; Lei P; Zha J; Zhu H; Gu X; Huang D
Breast Cancer Res Treat; 2019 May; 175(1):59-75. PubMed ID: 30715658
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of aberrantly expressed long non‑coding RNAs, microRNAs, and mRNAs associated with the competitive endogenous RNA network in cervical cancer.
Chen P; Zhang W; Chen Y; Zheng X; Yang D
Mol Med Rep; 2020 Jul; 22(1):405-415. PubMed ID: 32377727
[TBL] [Abstract][Full Text] [Related]
17. Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma.
Zhao J; Wang L; Wei B
Biomed Res Int; 2020; 2020():3708231. PubMed ID: 32802843
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide analysis of prognostic-related lncRNAs, miRNAs and mRNAs forming a competing endogenous RNA network in lung squamous cell carcinoma.
Ju Q; Zhao YJ; Ma S; Li XM; Zhang H; Zhang SQ; Yang YM; Yan SX
J Cancer Res Clin Oncol; 2020 Jul; 146(7):1711-1723. PubMed ID: 32356177
[TBL] [Abstract][Full Text] [Related]
19. Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue.
Zhou RS; Zhang EX; Sun QF; Ye ZJ; Liu JW; Zhou DH; Tang Y
BMC Cancer; 2019 Aug; 19(1):779. PubMed ID: 31391008
[TBL] [Abstract][Full Text] [Related]
20. Data Mining and Expression Analysis of Differential lncRNA ADAMTS9-AS1 in Prostate Cancer.
Wan J; Jiang S; Jiang Y; Ma W; Wang X; He Z; Wang X; Cui R
Front Genet; 2019; 10():1377. PubMed ID: 32153626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]